Deputy Health Minister Datuk Dr Noor Azmi Ghazali told the Dewan Rakyat that the government will review the procurement of antivirals to treat Covid-19 patients following the emergence of new drugs for this purpose.
He clarified that the decision to procure 150,000 courses of Molnupiravir from Merck Sharp & Dohme in early October was made because it was the only oral Covid-19 antiviral drug at that time.
Read more at https://bit.ly/3dnEh11
WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline
